C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2011
03/29/2011	CA2207815C Modulators of the function of fas/apo1 receptors
03/29/2011	CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment
03/29/2011	CA2165573C Anti-.alpha.v-integrin monoclonal antibody
03/24/2011	WO2011035205A2 Antibodies against candida, collections thereof and methods of use
03/24/2011	WO2011035101A1 Diagnostic tests for abnormal ovarian conditions
03/24/2011	WO2011034605A2 Coiled coil and/or tether containing protein complexes and uses thereof
03/24/2011	WO2011034582A2 Hiv-1 antibodies
03/24/2011	WO2011034128A1 Collagen neoepitope antibody
03/24/2011	WO2011033493A1 Carrier conjugates of il-23-peptides and their induced antibodies
03/24/2011	WO2011033105A1 Dosage regimen for administering an epcamxcd3 bispecific antibody
03/24/2011	WO2011032633A1 Treatment of autoimmune and inflammatory diseases with epratuzumab
03/24/2011	WO2010132604A3 Neutralizing molecules to influenza viruses
03/24/2011	WO2010127642A9 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof
03/24/2011	WO2010115210A3 Mouse models
03/24/2011	WO2010111516A3 Compositions and methods for inhibiting biofilms
03/24/2011	WO2010052467A3 Canine oral cavity probiotics
03/24/2011	US20110072539 Compositions and Methods for Modulating Pigment Production in Plants
03/24/2011	US20110072526 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/24/2011	US20110071278 Antibodies that recognize cutting edge within the tgf- beta activation controlling region
03/24/2011	US20110071277 Resistin antagonists and their use
03/24/2011	US20110071276 Method of modifying a monoclonal antibody
03/24/2011	US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
03/24/2011	US20110071087 Polypeptides having modulatory effects on cells
03/24/2011	US20110071046 Matrix screening method
03/24/2011	US20110070653 INHIBITOR OF HISTONE ACETYLTRANSFERASE, ESPECIALLY p300
03/24/2011	US20110070652 Phage microarray profiling of the humoral response to disease
03/24/2011	US20110070650 Method of Enhancing Homologous Recombination of Somatic Cells and Method of Acquiring Specific Antibody
03/24/2011	US20110070641 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
03/24/2011	US20110070620 Substrates comprising switchable ferromagnetic nanoparticles
03/24/2011	US20110070607 Glycoprotein synthesis and remodeling by enzymatic transglycosylation
03/24/2011	US20110070257 Polyvalent Chimeric OSPC Vaccinogen and Diagnostic Antigen
03/24/2011	US20110070256 Vaccine Antigens from Piscirickettsia Salmonis
03/24/2011	US20110070253 Tumour-associated peptides binding to mhc molecules
03/24/2011	US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN
03/24/2011	US20110070248 Dr5 ligand drug conjugates
03/24/2011	US20110070247 Protein modulators
03/24/2011	US20110070246 Antibodies Against CDCP1 for the Treatment of Cancer
03/24/2011	US20110070245 Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
03/24/2011	US20110070243 Compositions and methods for the treatment of tumor of hematopoietic
03/24/2011	US20110070238 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
03/24/2011	US20110070231 Stable liquid pharmaceutical formulation of igg antibodies
03/24/2011	US20110070226 Variable antibodies
03/24/2011	US20110070184 Methods and compositions for treating atherosclerosis and related condidtions
03/24/2011	US20110070163 Cancer cell migration and cancer cell invasion inhibitor
03/24/2011	US20110070156 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
03/24/2011	US20110070155 Anti-CD74 Immunoconjugates and Methods
03/24/2011	CA2781519A1 Coiled coil and/or tether containing protein complexes and uses thereof
03/24/2011	CA2774732A1 Dosage regimen for administering an epcamxcd3 bispecific antibody
03/24/2011	CA2774446A1 Hiv-1 antibodies
03/24/2011	CA2774260A1 Class i anti-cea antibodies and uses thereof
03/24/2011	CA2774244A1 Treatment of autoimmune and inflammatory diseases with epratuzumab
03/24/2011	CA2774212A1 Protein a crystals and cross-linked crystals and methods of use thereof
03/24/2011	CA2774053A1 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
03/24/2011	CA2771336A1 Synergistic anti-cd47 therapy for hematologic cancers
03/23/2011	EP2298910A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
03/23/2011	EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
03/23/2011	EP2298878A2 Compositions and methods for the diagnosis of cancer
03/23/2011	EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them
03/23/2011	EP2298868A2 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same
03/23/2011	EP2298817A1 Hybrid antibodies
03/23/2011	EP2298816A2 Apoptosis induced by an antibody against Her2
03/23/2011	EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules
03/23/2011	EP2298814A2 Method for quantifying phosphokinase activity on proteins
03/23/2011	EP2298813A2 Anti-TRKB monoclonal antibodies and uses thereof
03/23/2011	EP2298812A2 Remedies for juvenile chronic arthritis and related diseases
03/23/2011	EP2298811A2 Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors
03/23/2011	EP2298810A2 Treatment of TNF alpha related disorders
03/23/2011	EP2298809A2 Super humanized antibodies
03/23/2011	EP2298808A1 Anti-C5 antibodies and their therapeutic uses
03/23/2011	EP2298807A2 Antibodies directed against amyloid-beta peptide and methods using same
03/23/2011	EP2298806A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof
03/23/2011	EP2298805A2 Optimized Fc variants and methods for their generation
03/23/2011	EP2298804A2 Monoclonal antibody production by EBV transformation of B cells
03/23/2011	EP2298803A2 Human G-protein coupled receptor and ligands thereof
03/23/2011	EP2298802A1 T1R3 taste receptors and genes encoding same
03/23/2011	EP2298799A1 A gene encoding a multidrug resistance human p-glyoprotein homologue on chromosome 7p15-21 and uses thereof
03/23/2011	EP2298796A2 Staphylococcus aureus proteins and nucleic acids
03/23/2011	EP2298789A1 Mammalian genes; related reagents and methods
03/23/2011	EP2298717A1 Antibodies against monocyte chemotactic proteins
03/23/2011	EP2298355A2 Albumin fusion proteins
03/23/2011	EP2298354A2 Remodelling and glycoconjugation of interferon-beta
03/23/2011	EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease
03/23/2011	EP2298347A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder
03/23/2011	EP2298346A2 Human antibodies specific to kdr and uses thereof
03/23/2011	EP2298345A2 Specific binding members for NGF
03/23/2011	EP2298334A2 Tweak receptor
03/23/2011	EP2298333A2 Tweak receptor
03/23/2011	EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
03/23/2011	EP2297585A1 Detection of cannabis use
03/23/2011	EP2297582A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof.
03/23/2011	EP2297209A2 Dual variable domain immunoglobulins and uses thereof
03/23/2011	EP2297208A2 Dual variable domain immunoglobulins and uses thereof
03/23/2011	EP2297207A1 Use of anti-factors xi antibodies for prevention of thrombus formation
03/23/2011	EP2297206A1 Anti-cxcr4 antibodies
03/23/2011	EP2297205A1 Use of the irap protein for implementing methods of diagnosis and of prognosis
03/23/2011	EP2297204A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
03/23/2011	EP2297203A1 Anti-human interleukin-20 antibodies
03/23/2011	EP2297202A2 Anti-il-6/il-6r antibodies and methods of use thereof
03/23/2011	EP2297201A1 Antibody specific for propionylated/butyrylated lysine, method for obtaining same and uses thereof
03/23/2011	EP2297200A1 Anti influenza antibodies and uses thereof

1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 1494